Your browser doesn't support javascript.
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?
Lee, Todd C; Butler-Laporte, Guillaume; Chagla, Zain; McDonald, Emily G.
  • Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada; Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada; Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada. Electronic
  • Butler-Laporte G; Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.
  • Chagla Z; Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • McDonald EG; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada; Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada.
Clin Microbiol Infect ; 27(2): 158-159, 2021 02.
Article in English | MEDLINE | ID: covidwho-1336345

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article